[ET Net News Agency, 25 June 2021] ALPHAMAB-B (09966) rose 1.8% to HK$25.5.
It hits an intra-day high of HK$26, hitting a historical high, and an intra-day low of
HK$25.3. The total shares traded was 224,500, with a value of HK$5.76m. The active
buy/sell ratio is 77:23, with net buying turnover of HK$2.97m. CREDIT SUISSE (HK) SEC
accounts for greatest net responsive buying turnover of HK$387,000, with volume weighted
average price of HK$25.8. ZHONGTAI INT'L SEC accounts for greatest net responsive selling
turnover of HK$475,625, with volume weighted average price of HK$25.709. The stock has
risen a combined 23.19% over the past 7 consecutive trading days.
The Hang Seng Index now rose 133 points, or 0.46% to 29,016; the Hang Seng China
Enterprises Index now rose 57 points, or 0.54% to 10,734; the Hang Seng TECH Index now
rose 74 points, or 0.92% to 8,114; with an overall turnover of HK$8.54b.
The SSE Composite Index now rose 2 points, or 0.07% to 3,568, with an overall turnover
of RMB17.53b.
The SZSE Component Index now rose 40 points, or 0.27% to 14,825, with an overall
turnover of RMB7.96b.

Basic Information
-------------------------------------------
Nominal 25.500 % Chg +1.80%
High 26.000 Low 25.300
Shares Tr 224,500 Turnover 5.76m
10-D SMA 22.530 %H.V 71.067
20-D SMA 21.128 VWAP 25.659
50-D SMA 17.848 RSI14 71.760
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 77:23, with net buying
turnover of HK$2.97m, rising a combined 23.19% over the past 7 consecutive
trading days

Table: Performance of stocks in the same sector or of relevance

Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
ALPHAMAB-B (09966) 25.50 +1.80
GENSCRIPT BIO (01548) 34.55 -0.43
INNOVENT BIO (01801) 91.35 -0.38
JUNSHI BIO (01877) 66.55 -0.37
JXR (01951) 20.75 -0.95
WUXI BIO (02269) 140.20 +1.01
CSTONE PHARMA-B (02616) 18.04 +0.56
TIGERMED (03347) 172.90 +2.19
CANSINOBIO-B (06185) 426.00 +1.19
KINTOR PHARMA-B (09939) 57.45 -0.95
-------------------------------------------------
(ed)